GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (XSWX:VIFN) » Definitions » PEG Ratio

Vifor Pharma AG (XSWX:VIFN) PEG Ratio : 3.99 (As of May. 06, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Vifor Pharma AG PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Vifor Pharma AG's PE Ratio without NRI is 73.84. Vifor Pharma AG's 5-Year EBITDA growth rate is 18.50%. Therefore, Vifor Pharma AG's PEG Ratio for today is 3.99.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Vifor Pharma AG's PEG Ratio or its related term are showing as below:

XSWX:VIFN' s PEG Ratio Range Over the Past 10 Years
Min: 2.96   Med: 8.78   Max: 11.04
Current: 4.19


During the past 13 years, Vifor Pharma AG's highest PEG Ratio was 11.04. The lowest was 2.96. And the median was 8.78.


XSWX:VIFN's PEG Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.775 vs XSWX:VIFN: 4.19

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Vifor Pharma AG PEG Ratio Historical Data

The historical data trend for Vifor Pharma AG's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG PEG Ratio Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 10.03 3.85

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 10.03 - 3.85

Competitive Comparison of Vifor Pharma AG's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vifor Pharma AG's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's PEG Ratio falls into.



Vifor Pharma AG PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Vifor Pharma AG's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=73.844444444444/18.50
=3.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Vifor Pharma AG  (XSWX:VIFN) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Vifor Pharma AG PEG Ratio Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (XSWX:VIFN) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (XSWX:VIFN) Headlines

No Headlines